Biotest AG: Biotest supports clinical study with Pentaglobin(R) in COVID-19 at the University Hospital AKH Vienna
PharmiWeb,
DGAP-News: Biotest AG / Key word(s): Study 23.02.2021 / 07:00 The issuer is solely responsible for the content of this…
DGAP-News: Biotest AG / Key word(s): Study 23.02.2021 / 07:00 The issuer is solely responsible for the content of this…
DGAP-News: Biotest AG / Schlagwort(e): Studie 23.02.2021 / 07:00 Für den Inhalt der Mitteilung ist der Emittent / Herausgeber…
DGAP-News: Biotest AG / Key word(s): Study Biotest AG: Biotest supports clinical study with Pentaglobin(R) in COVID-19 at the…
DGAP-News: Biotest AG / Key word(s): Study 23.02.2021 / 07:00 The issuer is solely responsible for the content of this…
Biotest AG, DE0005227235 Pentaglobin(R) wirkt immun-modulatorisch und k?nnte somit helfen, die oft ?berschie?ende Immunantwort…
DGAP-News: Biotest AG / Key word(s): Research Update 26.11.2020 / 07:00 The issuer is solely responsible for the content of…
DGAP-News: Biotest AG / Key word(s): Research Update 26.11.2020 / 07:00 The issuer is solely responsible for the content of…
DGAP-News: Biotest AG / Key word(s): Research Update 26.11.2020 / 07:00 The issuer is solely responsible for the content of…
Patienten, die zusätzlich von bakteriellen Infektionen betroffen sind 26.11.2020..."> DGAP-News: Biotest AG / Schlagwort(e)…
DGAP-News: Biotest AG / Schlagwort(e): Research Update 26.11.2020 / 07:00 Für den Inhalt der Mitteilung ist der Emittent …
DGAP-News: Biotest AG / Key word(s): Research Update 26.11.2020 / 07:00 The issuer is solely responsible for the content of…
DGAP-News: Biotest AG / Key word(s): Research Update Biotest AG: Biotests Pentaglobin(R) is a treatment option for COVID-19…
DGAP-News: Biotest AG / Key word(s): Research Update 26.11.2020 / 07:00 The issuer is solely responsible for the content of…